Publication | Closed Access

Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3

Hepatocellular CarcinomaOncogenic AgentPathologyTissue InhibitorsTumor TargetingLiver CancerMedicineRadiation OncologyTumor MicroenvironmentCancer Research